
Reaching new heights by working together: Innovative industry partnership
RI-MUHC-led team will use artificial intelligence to improve survival rates of cancer-diagnosed patients

RI-MUHC trainee wins Best Oral Presentation at Skin Research Group of Canada Conference
Congratulations to Jennifer Gantchev!

Driving Personalized Medicine: The 2020 RI-MUHC Annual Report is online!
An invitation from Dr. Miguel Burnier Jr.

New services for cancer patients at the RI-MUHC Centre for Innovative Medicine
The Centre for Innovative Medicine and Cedars Cancer Centre jointly offer additional space for infusion treatments

RI-MUHC researcher earns Quebec’s highest honour for research in biomedicine
William Foulkes awarded 2020 Wilder Penfield Prize for research in the genetics of breast and ovarian cancer ...

Project led by RI-MUHC researchers wins award at Oncopole's Priorité patient Competition
New grant supports integration of peer support and counselling ...

Former RI-MUHC trainee named a member of the CIHR’s new nationwide Youth Advisory Council
Congratulations to Wajih Jawhar of the Cancer Research Program!

Protecting lung cancer patients from COVID-19 – and learning from the experience
A study led by Dr. Nathaniel Bourganim tracked changes in treatment plans

RI-MUHC researchers receive federal grants through the CFI's John R. Evans Leaders Fund
Congratulations to four RI-MUHC researchers!

Canada Research Chairs Program announces new and renewed chairs
Congratulations to five RI-MUHC researchers in the spring 2020 round!

Dr. Armen Aprikian appointed Clinical Lead, Rossy Cancer Network
A leading urologic oncologist and researcher takes the helm

Reflecting on my Master’s in Experimental Medicine experience
Dermatology resident Abdulhadi Jfri shares his thoughts on undertaking a simultaneous Master’s degree

COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study
Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality

Results of MI4 Emergency COVID-19 Research Funding (Round 2)
RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe

$1.3M to develop a non-invasive positron detector for medical imaging
Congratulations to Shirin Abbasinejad Enger!

International consortium investigates overactive immune cells as cause of COVID-19 deaths
New publication links neutrophil infiltration in the lungs of patients to COVID-19 symptoms

Ovarian and endometrial cancers: $ 6M closer to a lifesaving screening pap test
Dr. Lucy Gilbert’s research team receives funding to finalize development of the DOvEEgene test

The Pfizer Investigator Training Program comes to the RI-MUHC!
Clinical research educational training program benefits researchers, staff and students at the inaugural event

Sexual dimorphism: The female hormone estrogen may facilitate the growth of liver metastases in non-sex-specific cancers
Study published in Nature Communications

Two national organizations honour former RI-MUHC trainee
A first-place finish for Julien Mégrourèche in the J.R. Cunningham Young Investigators Awards, along with “Best in Physics” award this fall